Odyssey raises more than $300M as biotech goes public
Odyssey融资超3亿美元，生物科技公司即将上市

Odyssey Therapeutics pulled together $279 million from its initial public offering, the autoimmune disease drug developer said Thursday night.
自身免疫性疾病药物开发商Odyssey Therapeutics周四晚间表示，其通过首次公开募股筹集了2.79亿美元。